Showing results (91-100 of 147) with videos related to
Sort By:
Pageof 15
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.The American Journal of Gastroenterology|February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment TrialJordan J Feld, Abdus S Wahed, Michael Fried, et al.Gastroenterology|March 10, 2010
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Detection and characterization of Hepatitis B virus double-stranded linear DNA-derived covalently closed circular DNA in chronic hepatitis B patientsHsin-Ni Liu, Elena Kim, Zhili Wang, et al.Hepatology (Baltimore, Md.)|December 15, 2018
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus InfectionJordan J Feld, Norah A Terrault, Hsing-Hua S Lin, et al.The American Journal of Gastroenterology|April 1, 2006
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trialRobert J Fontana, Arun J Sanyal, Savant Mehta, et al.Journal of Viral Hepatitis|August 6, 2021
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort studyWilliam M Lee, Wendy C King, Harry L A Janssen, et al.Hepatology (Baltimore, Md.)|June 30, 2022
HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapyMauricio Lisker-Melman, Abdus S Wahed, Marc G Ghany, et al.Hepatology (Baltimore, Md.)|December 25, 2007
Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) TrialLeonard B Seeff, Teresa M Curto, Gyongyi Szabo, et al.Pageof 15